CALIDI BIOTHERAPEUTICS INC (CLDI)
AMEXHealth CareBiotechnologySnapshot 2026-09-04
$1.39+2.96%
Close 2026-09-04 · 1-day change
AMEXHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · CLDI
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | |
|---|---|---|---|---|---|---|
| Revenues | ||||||
| Revenues | — | — | — | — | 0.0 | — |
| Operating Expenses & Income | ||||||
| Selling, General & Admin | 8.0 | 10.5 | 12.9 | 16.0 | 15.9 | — |
| R&D Expenses | 9.9 | 9.7 | 8.9 | 13.0 | 7.3 | — |
| Operating Income | (17.9) | (20.2) | (21.8) | (29.0) | (23.1) | — |
| Earnings from Continuing Operations | ||||||
| Other Non-Operating Income / Expenses | 0.4 | 0.2 | (0.4) | (0.2) | (2.3) | — |
| EBT, Incl. Unusual Items | (17.5) | (20.0) | (22.2) | (29.2) | (25.4) | — |
| Income Tax Expense | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — |
| Net Income | ||||||
| Minority Interest | — | (0.2) | (0.1) | — | — | — |
| Net Income | (17.5) | (19.9) | (22.1) | (29.2) | (25.4) | — |
| Per Share | ||||||
| Basic EPS | (12.34) | (5.95) | (2.97) | (17.33) | 2.99 | — |
| Diluted EPS | (12.34) | (5.95) | (2.97) | (17.33) | 2.99 | — |
| Basic Weighted Avg Shares | 1.4 | 0.0 | 8.0 | 1.7 | 8.5 | — |
| Diluted Weighted Avg Shares | 1.4 | 0.0 | 8.0 | 1.7 | 8.5 | — |
| Supplemental | ||||||
| EBITDA | — | (18.6) | — | — | — | — |
| EBIT | (17.9) | (20.2) | (21.8) | (29.0) | (23.1) | — |
| Effective Tax Rate | -0.1% | — | — | -0.1% | -0.0% | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.